Navigation Links
Keystone Symposia launches 2013-14 meeting series with first conference in Rio de Janeiro
Date:11/1/2013

Keystone Symposia is today convening the first conference of its 2013-2014 meeting season and its first in Rio de Janeiro, Brazil on "Advancing Vaccines in the Genomics Era" at the Windsor Barra Hotel immediately following the conclusion of the Grand Challenges in Global Health meeting for that program's grantees. The four-day conference is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, which has funded travel awards for 27 investigators from developing countries to attend. It is also sponsored by FAPERJ the Rio de Janeiro State Agency for Research Development.

Scientific organizers of the meeting are Bali Pulendran of Emory University, Chris Wilson of Bill & Melinda Gates Foundation and Rino Rappuoli of Novartis Vaccines & Diagnostics.The focus is on the design and development of vaccines leveraging advances in systems and structural biology.

One of the key presentations at the meeting will be by Peter Kwong of the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health on Sunday morning, November 3. His paper, published in Science on November 1, demonstrates the efficacy of a new fusion glycoprotein vaccine for RSV (Respiratory Syncytial Virus), which was developed at NIAID using structure-based design. RSV is the leading cause of hospitalization for children under five years of age, plus responsible for 6.75% of deaths in children one month to one year of age and in the elderly at levels comparable to influenza virus. The vaccine is the first time the "Antibody-to-Vaccine" paradigm driving the HIV and universal flu efforts has been shown to work. More details are available in NIAID's press release at http://www.niaid.nih.gov/news/newsreleases/2013/Pages/RSV-vax.aspx.

"The publication of the work on RSV as our meeting convenes in Rio is an additional demonstration of how new, revolutionary technologies are making it possible to develop novel vaccines, and how timely and important is this Keystone Symposia meeting," commented Rino Rappuoli.


'/>"/>

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology
Source:Eurekalert

Related biology news :

1. Keystone Symposia announces grant from Alfred P. Sloan Foundation
2. Natural keystone molecules punch over their weight in ecosystems
3. Entomology 2012 to present 105 insect symposia in November
4. BiOptix to highlight new 404pi instrument at European symposia
5. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
6. Elsevier launches new journal Algal Research
7. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
8. Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
9. WanderID Launches Breakthrough ID Product for Children, Seniors
10. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
11. MindSpec launches online Autism Reading Room
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  According to new research ... mainstream. More than 200 fingerprint, iris, and eye-vein ... under 70 brand names. This includes market leaders ... ZTE. Acuity projects that 600 million biometric smartphones ... global installed base. Maxine Most , ...
(Date:2/11/2016)... Feb. 11, 2016  Vigilant Solutions announces today that its ... being used by Lee,s Summit Police ... location and arrest of a homicide suspect. ... covers around 65 square miles and is home to roughly ... has a single mobile license plate reader system and also ...
(Date:2/10/2016)... February 10, 2016 ... to 2016 iris recognition market report, combined ... is more widely accepted for border control. ... fingerprint and iris recognition technology in a ... avoid purchasing two individual biometrics devices. ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... , February 11, 2016 Non-profit ... Promote Genetic Understanding to Support Research and Discovery ... 100K, today announced an ambitious plan to sequence 100,000 individuals. ... Asian countries and at least 7 of North and East ... In the first phase, the project will focus on creating ...
(Date:2/11/2016)... Biosciences, Inc. (NASDAQ: NBIX ) today announced its financial results ... --> --> For the fourth quarter ... or $0.34 loss per share, compared to a net loss of ... in 2014. For the year ended December 31, 2015, the Company ... share, as compared to a net loss of $60.5 million, or ...
(Date:2/11/2016)... 11, 2016  Vermillion, Inc. (NASDAQ: VRML ), ... announced the formation of the Steering Committee for its ... --> Pelvic masses can present physicians and ... Once pregnancy is ruled out, pelvic masses may include ... endometriosis, benign ovarian tumors and gastrointestinal and urinary tract ...
(Date:2/11/2016)... Germany and GERMANTOWN, Maryland ... QGEN ; Frankfurt Prime Standard: QIA) today announced the ... Panels for gene expression profiling, expanding QIAGEN,s portfolio of ... panels enable researchers to select from over 20,000 human ... discover interactions between genes, cellular phenotypes and disease processes. ...
Breaking Biology Technology: